Adooq Bioscience

Adooq Bioscience logo

AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.

Company Website

Product Listing

Olodaterol 5mg 5mg  | Purity Not Available

Adooq Bioscience

Olodaterol is a long acting beta-adrenoceptor agonist used as an inhalation for treating patients with chronic obstructive pulmonary disease (COPD), manufactured by Boehringer-Ingelheim.

More Information Supplier Page

Ombrabulin 10mg 10mg  | Purity Not Available

Adooq Bioscience

Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.

More Information Supplier Page

Ombrabulin 25mg 25mg  | Purity Not Available

Adooq Bioscience

Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.

More Information Supplier Page

Ombrabulin 50mg 50mg  | Purity Not Available

Adooq Bioscience

Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.

More Information Supplier Page

Ombrabulin 5mg 5mg  | Purity Not Available

Adooq Bioscience

Ombrabulin is a synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities.

More Information Supplier Page

ON-01910 100mg 100mg  | Purity Not Available

Adooq Bioscience

ON-01910 is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

More Information Supplier Page

ON-01910 10mg 10mg  | Purity Not Available

Adooq Bioscience

ON-01910 is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

More Information Supplier Page

ON-01910 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

ON-01910 is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

More Information Supplier Page

ON-01910 50mg 50mg  | Purity Not Available

Adooq Bioscience

ON-01910 is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

More Information Supplier Page

ON-01910 5mg 5mg  | Purity Not Available

Adooq Bioscience

ON-01910 is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.

More Information Supplier Page

Oncrasin 1 10mg 10mg  | Purity Not Available

Adooq Bioscience

Oncrasin 1 is a proapoptotic substance. Induces abnormal nuclear aggregation of PKC?? and suppressing RNA transcription.

More Information Supplier Page

Oncrasin 1 50mg 50mg  | Purity Not Available

Adooq Bioscience

Oncrasin 1 is a proapoptotic substance. Induces abnormal nuclear aggregation of PKC?? and suppressing RNA transcription.

More Information Supplier Page

Ondansetron 100mg 100mg  | Purity Not Available

Adooq Bioscience

Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic (to treat nausea and vomiting). Ondansetron reduces the activity of the vagus nerve, which deactivates the vomiting center in the medulla oblongata, and also blocks serotonin receptors in the chemoreceptor trigger zone.

More Information Supplier Page

Ondansetron 10mg 10mg  | Purity Not Available

Adooq Bioscience

Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic (to treat nausea and vomiting). Ondansetron reduces the activity of the vagus nerve, which deactivates the vomiting center in the medulla oblongata, and also blocks serotonin receptors in the chemoreceptor trigger zone.

More Information Supplier Page

Ondansetron 50mg 50mg  | Purity Not Available

Adooq Bioscience

Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic (to treat nausea and vomiting). Ondansetron reduces the activity of the vagus nerve, which deactivates the vomiting center in the medulla oblongata, and also blocks serotonin receptors in the chemoreceptor trigger zone.

More Information Supplier Page

Onjisaponin B 10mg 10mg  | Purity Not Available

Adooq Bioscience

Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant a-Synuclein and Huntingtin in PC-12 Cells.

More Information Supplier Page

Onjisaponin B 25mg 25mg  | Purity Not Available

Adooq Bioscience

Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant a-Synuclein and Huntingtin in PC-12 Cells.

More Information Supplier Page

Onjisaponin B 5mg 5mg  | Purity Not Available

Adooq Bioscience

Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant a-Synuclein and Huntingtin in PC-12 Cells.

More Information Supplier Page

Ononin 1mg 1mg  | Purity Not Available

Adooq Bioscience

Onionin is a isoflavone glucoside found in soybean, kudzu, and the Chinese medicinal herb, Radix astragali (RA).

More Information Supplier Page

Ononin 5mg 5mg  | Purity Not Available

Adooq Bioscience

Onionin is a isoflavone glucoside found in soybean, kudzu, and the Chinese medicinal herb, Radix astragali (RA).

More Information Supplier Page

ONT-093 10mg 10mg  | Purity Not Available

Adooq Bioscience

ONT-093 is an orally bioavailable P-glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy.

More Information Supplier Page